T1	Disorder 427 430	IPF
T3	Method_cue 123 136	meta-analysis
T7	Anatomical_entity 1518 1523	serum
T8	Disorder 1581 1584	IPF
T11	Anatomical_entity 2212 2217	Serum
T12	Anatomical_entity 506 511	serum
T13	Disorder 990 1009	pulmonary infection
T20	Disorder 443 446	IPF
T21	Disorder 953 956	IPF
T23	GGPs 1217 1221	SP-A
T25	Disorder 165 194	Idiopathic pulmonary fibrosis
T29	Anatomical_entity 10 15	serum
T30	Subject 1258 1266	patients
T35	Disorder 196 199	IPF
T36	Disorder 2059 2062	IPF
T38	Anatomical_entity 1211 1216	Serum
T40	Disorder 2322 2325	IPF
T42	GGPs 1978 1982	SP-D
T43	Disorder 912 915	IPF
T45	Disorder 1725 1744	pulmonary infection
T46	Disorder 1302 1305	IPF
T47	Disorder 1558 1561	IPF
T48	Disorder 957 982	interstitial lung disease
T55	Disorder 984 987	ILD
T56	Method_cue 1196 1209	meta-analysis
T57	Disorder 1355 1374	pulmonary infection
T58	GGPs 1956 1960	SP-A
T60	Disorder 1699 1702	IPF
T61	Subject 1866 1874	patients
T62	Anatomical_entity 1897 1902	serum
T63	GGPs 2218 2222	SP-A
T65	GGPs 550 554	SP-D
T66	Anatomical_entity 869 874	serum
T68	Subject 1589 1597	patients
T70	GGPs 2070 2074	SP-A
T73	Subject 1711 1719	patients
T75	GGPs 16 20	SP-A
T76	GGPs 541 545	SP-A
T77	Anatomical_entity 1638 1643	Serum
T80	Disorder 1585 1588	ILD
T81	GGPs 25 29	SP-D
T89	Disorder 1272 1275	IPF
T93	Method_cue 463 476	meta-analysis
T97	Disorder 1159 1162	IPF
T99	Subject 2169 2174	Asian
T101	Subject 935 943	patients
T104	GGPs 885 889	SP-A
T105	Subject 1685 1693	patients
T106	Anatomical_entity 2064 2069	serum
T107	GGPs 1524 1528	SP-D
T110	Subject 1938 1946	patients
T112	Disorder 68 97	idiopathic pulmonary fibrosis
T113	GGPs 1903 1907	SP-A
T122	Disorder 1306 1309	ILD
T123	Subject 2179 2188	Caucasian
T124	Subject 2308 2316	patients
T125	Subject 1284 1292	patients
T127	Disorder 600 603	IPF
T128	Subject 898 906	patients
T129	Disorder 1880 1883	IPF
T130	Subject 1015 1030	healthy control
T132	Subject 2189 2197	patients
T133	GGPs 1644 1648	SP-D
T134	GGPs 2028 2032	SP-D
T137	Subject 1154 1158;1163 1171	1289 patients
T141	Subject 1544 1552	patients
N2	Reference T1 UMLS:C1800706	Idiopathic Pulmonary Fibrosis
N14	Reference T3 UMLS:C0920317	Meta Analysis (statistical procedure)
N33	Reference T7 UMLS:C0229671	Serum
N35	Reference T8 UMLS:C1800706	Idiopathic Pulmonary Fibrosis
N50	Reference T11 UMLS:C0229671	Serum
N55	Reference T12 UMLS:C0229671	Serum
N56	Reference T13 UMLS:C0876973	Infectious disease of lung
N78	Reference T20 UMLS:C1800706	Idiopathic Pulmonary Fibrosis
N81	Reference T21 UMLS:C1800706	Idiopathic Pulmonary Fibrosis
N91	Reference T25 UMLS:C1800706	Idiopathic Pulmonary Fibrosis
N104	Reference T29 UMLS:C0229671	Serum
N105	Reference T30 UMLS:C0030705	Patients
N119	Reference T35 UMLS:C1800706	Idiopathic Pulmonary Fibrosis
N123	Reference T36 UMLS:C1800706	Idiopathic Pulmonary Fibrosis
N131	Reference T38 UMLS:C0229671	Serum
N137	Reference T40 UMLS:C1800706	Idiopathic Pulmonary Fibrosis
N150	Reference T42 UMLS:C0084692	Pulmonary Surfactant-Associated Protein D
N152	Reference T43 UMLS:C1800706	Idiopathic Pulmonary Fibrosis
N157	Reference T45 UMLS:C0876973	Infectious disease of lung
N160	Reference T46 UMLS:C1800706	Idiopathic Pulmonary Fibrosis
N163	Reference T47 UMLS:C1800706	Idiopathic Pulmonary Fibrosis
N165	Reference T48 UMLS:C0206062	Lung Diseases, Interstitial
N187	Reference T55 UMLS:C0206062	Lung Diseases, Interstitial
N192	Reference T56 UMLS:C0920317	Meta Analysis (statistical procedure)
N193	Reference T57 UMLS:C0876973	Infectious disease of lung
N199	Reference T60 UMLS:C1800706	Idiopathic Pulmonary Fibrosis
N202	Reference T61 UMLS:C0030705	Patients
N208	Reference T62 UMLS:C0229671	Serum
N224	Reference T65 UMLS:C0084692	Pulmonary Surfactant-Associated Protein D
N229	Reference T66 UMLS:C0229671	Serum
N232	Reference T68 UMLS:C0030705	Patients
N244	Reference T73 UMLS:C0030705	Patients
N258	Reference T77 UMLS:C0229671	Serum
N265	Reference T80 UMLS:C0206062	Lung Diseases, Interstitial
N273	Reference T81 UMLS:C0084692	Pulmonary Surfactant-Associated Protein D
N304	Reference T89 UMLS:C1800706	Idiopathic Pulmonary Fibrosis
N317	Reference T93 UMLS:C0920317	Meta Analysis (statistical procedure)
N324	Reference T97 UMLS:C1800706	Idiopathic Pulmonary Fibrosis
N331	Reference T99 UMLS:C0078988	Asians
N338	Reference T101 UMLS:C0030705	Patients
N350	Reference T105 UMLS:C0030705	Patients
N356	Reference T106 UMLS:C0229671	Serum
N363	Reference T107 UMLS:C0084692	Pulmonary Surfactant-Associated Protein D
N368	Reference T110 UMLS:C0030705	Patients
N372	Reference T112 UMLS:C1800706	Idiopathic Pulmonary Fibrosis
N411	Reference T122 UMLS:C0206062	Lung Diseases, Interstitial
N414	Reference T123 UMLS:C0043157	Caucasians
N416	Reference T124 UMLS:C0030705	Patients
N418	Reference T125 UMLS:C0030705	Patients
N423	Reference T127 UMLS:C1800706	Idiopathic Pulmonary Fibrosis
N425	Reference T128 UMLS:C0030705	Patients
N428	Reference T129 UMLS:C1800706	Idiopathic Pulmonary Fibrosis
N430	Reference T130 UMLS:C2986479	Healthy Control
N434	Reference T132 UMLS:C0030705	Patients
N442	Reference T133 UMLS:C0084692	Pulmonary Surfactant-Associated Protein D
N449	Reference T134 UMLS:C0084692	Pulmonary Surfactant-Associated Protein D
N454	Reference T137 UMLS:C0030705	Patients
N467	Reference T141 UMLS:C0030705	Patients
T136	Biological_process 2037 2055	acute exacerbation
E10	Biological_process:T136 Theme:T36
N1	Reference E10 UMLS:C0743630	exacerbation acute
N3	Reference T75 UMLS:C0143146	Pulmonary Surfactant-Associated Protein A
T41	GGPs 512 533	surfactant proteins A
N5	Reference T41 UMLS:C0143146	Pulmonary Surfactant-Associated Protein A
N6	Reference T76 UMLS:C0143146	Pulmonary Surfactant-Associated Protein A
N7	Reference T104 UMLS:C0143146	Pulmonary Surfactant-Associated Protein A
N8	Reference T23 UMLS:C0143146	Pulmonary Surfactant-Associated Protein A
N9	Reference T113 UMLS:C0143146	Pulmonary Surfactant-Associated Protein A
N10	Reference T58 UMLS:C0143146	Pulmonary Surfactant-Associated Protein A
N11	Reference T70 UMLS:C0143146	Pulmonary Surfactant-Associated Protein A
N12	Reference T63 UMLS:C0143146	Pulmonary Surfactant-Associated Protein A
T115	GGPs 512 531;538 539	surfactant proteins D
N16	Reference T115 UMLS:C0084692	Pulmonary Surfactant-Associated Protein D
T143	GGPs 885 888;890 891	SP- D
N18	Reference T143 UMLS:C0084692	Pulmonary Surfactant-Associated Protein D
T144	GGPs 2070 2073;2075 2076	SP- D
N20	Reference T144 UMLS:C0084692	Pulmonary Surfactant-Associated Protein D
T145	GGPs 2218 2221;2223 2224	SP- D
N22	Reference T145 UMLS:C0084692	Pulmonary Surfactant-Associated Protein D
T4	Subject 1420 1436	healthy controls
N15	Reference T4 UMLS:C2986479	Healthy Control
T18	Subject 1790 1806	healthy controls
N23	Reference T18 UMLS:C2986479	Healthy Control
T39	Subject 1961 1967	groups
N26	Reference T39 UMLS:C1257890	Population Group
R1	Subject_Disorder Arg1:T128 Arg2:T43	
R2	Subject_Disorder Arg1:T137 Arg2:T97	
R3	Subject_Disorder Arg1:T30 Arg2:T89	
R4	Subject_Disorder Arg1:T141 Arg2:T47	
R5	Subject_Disorder Arg1:T105 Arg2:T60	
R6	Subject_Disorder Arg1:T73 Arg2:T45	
R7	Subject_Disorder Arg1:T61 Arg2:T129	
R8	Subject_Disorder Arg1:T124 Arg2:T40	
T34	Positive_regulation 1888 1896	elevated
E8	Positive_regulation:T34 Theme:T113 atLoc:T62
N29	Reference E8 UMLS:C1879547	Activation action
T52	Positive_regulation 1969 1977	Elevated
E11	Positive_regulation:T52 Theme:T42
N30	Reference E11 UMLS:C1879547	Activation action
T82	Positive_regulation 1983 1992	increased
E12	Positive_regulation:T82 Cause:E11
N31	Reference E12 UMLS:C1879547	Activation action
T86	Positive_regulation 1912 1921	increased
E13	Positive_regulation:T86 Theme:E1
N32	Reference E13 UMLS:C1879547	Activation action
T92	Subject 935 943	patients
N34	Reference T92 UMLS:C0030705	Patients
R9	Subject_Disorder Arg1:T101 Arg2:T13	
T135	Subject 2189 2197	patients
N41	Reference T135 UMLS:C0030705	Patients
T146	Subject 1284 1292	patients
N42	Reference T146 UMLS:C0030705	Patients
R10	Subject_Disorder Arg1:T125 Arg2:T57	
R11	member_of Arg1:T135 Arg2:T99	
R12	member_of Arg1:T132 Arg2:T123	
R13	member_of Arg1:T39 Arg2:T110	
T6	Biological_process 1857 1862	death
E1	Biological_process:T6 Theme:T61
N24	Reference E1 UMLS:C0011065	Cessation of life
T15	Artificial_process 560 582	differential diagnosis
E3	Artificial_process:T15 Instrument:T41 Instrument2:T115 Cue:T93 Cue2:T16 Theme:T127
N13	Reference E3 UMLS:C0011906	Differential Diagnosis
T19	Artificial_process 418 426	diagnose
E4	Artificial_process:T19 Theme:T1
N25	Reference E4 UMLS:C0011900	Diagnosis
T26	Artificial_process 587 596	prognosis
E7	Artificial_process:T26 Instrument:T41 Instrument2:T115 Cue:T93 Cue2:T16 Theme:T33
N28	Reference E7 UMLS:C0033325	Forecast of outcome
T33	Disorder 600 603	IPF
N43	Reference T33 UMLS:C1800706	Idiopathic Pulmonary Fibrosis
T22	Artificial_process 2255 2277	differential diagnosis
E2	Artificial_process:T22 Theme:T40 Cue:T24 Instrument:T63 Instrument2:T145
N45	Reference E2 UMLS:C0011906	Differential Diagnosis
T14	Biological_process 313 332	disease progression
E5	Biological_process:T14 
N17	Reference E5 UMLS:C0242656	Disease Progression
R23	Subject_Disorder Arg1:T68 Arg2:T80	
T16	Speculation_cue 486 494	evaluate
A1	Speculated E3
A2	Speculated E7
R24	part_of Arg1:T66 Arg2:T128	
R25	part_of Arg1:T66 Arg2:T101	
R26	part_of Arg1:T66 Arg2:T92	
R27	part_of Arg1:T66 Arg2:T130	
R17	part_of Arg1:T38 Arg2:T30	
R28	part_of Arg1:T38 Arg2:T125	
R29	part_of Arg1:T38 Arg2:T146	
R30	Subject_Disorder Arg1:T146 Arg2:T122	
R31	part_of Arg1:T38 Arg2:T4	
R32	part_of Arg1:T7 Arg2:T141	
R33	part_of Arg1:T7 Arg2:T68	
R18	part_of Arg1:T77 Arg2:T105	
R34	part_of Arg1:T77 Arg2:T73	
R35	part_of Arg1:T77 Arg2:T18	
T24	Speculation_cue 2235 2240	might
A3	Speculated E2
